Recent news on Rabeprazole Sodium

Teva Provides Update on Generic Aciphex Litigation  -  May 14, 2007
SpiritIndia,The FDA has already granted final approval for Teva's Abbreviated New Drug Application (ANDA) for Rabeprazole Sodium Delayed-Release Tablets, 20 mg.

Southern District Court of New York Rules Patent for ACIPHEX ...  -  May 14, 2007
SpiritIndia,PriCara™, Unit of Ortho-McNeil, Inc., announced that the Southern District Court of New York ruled that the patent for ACIPHEX® (rabeprazole sodium 20 mg

Dr. Reddy's may appeal Eisai patent verdict  -  May 14, 2007
NDTV.com,Aciphex, known chemically as rabeprazole sodium, belongs to a lucrative class of drugs known as proton pump inhibitors designed to suppress production of

Broadway Actress/HIV Advocate, Sheryl Lee Ralph, Unveils Winning ...  -  Apr 16, 2007
Drug Newswire (press release),...rifampin, St. John's wort (Hypericum perforatum), AcipHex(R) (rabeprazole sodium), Nexium(R) (esomeprazole magnesium), Prevacid(R) (lansoprazole),

First-Time Generic Approvals: Aciphex, Zantac Syrup, Uniretic  -  Mar 13, 2007
Medscape (subscription)March 13, 2007 — The US Food and Drug Administration (FDA) has approved first-time generic formulations for rabeprazole sodium 20-mg delayed-release tablets

Eisai acquires US oncology expert Morphotek for $325 million  -  Mar 23, 2007
Pharma Times (subscription),...strategy to reduce reliance on top-selling brands Aricept (donepezil) for Alzheimer's disease and gastrointestinal drug Aciphex (rabeprazole sodium).

WR Hambrecht: Asiphex will up Teva profit $0.18 per share  -  Feb 25, 2007
Globes,Ltd. (Nasdaq: TEVA; TASE: TEVA) to produce generic Aciphex (Rabeprazole Sodium) could add $151 million revenue and earnings per share of about $0.18.

WR Hambrecht: Asiphex will up Teva profit $0.18 per share  -  25 Feb 2007
Globes,Ltd. (Nasdaq: TEVA; TASE: TEVA) to produce generic Aciphex (Rabeprazole Sodium) could add $151 million revenue and earnings per share of about $0.18.

Teva Announces Approval of Rabeprazole Sodium Delayed-Release Tablets  -  Feb 22, 2007
PharmaLive.com (press release),Teva's Rabeprazole Sodium Delayed-Release Tablets are the AB-rated generic equivalent of Eisai's acid pump inhibitor Aciphex(R) Tablets.

Market Report -- In Play (TEVA)  -  Feb 22, 2007
MSN MoneyTeva Pharm announces approval of Rabeprazole Sodium Delayed-Release Tablets Co announces that the FDA has granted final approval for the Company's

Teva gets FDA approval for generic Aciphex  -  Feb 22, 2007
Globes,Rabeprazole Sodium is the generic version of Aciphex, an acid pump inhibitor made by Eisai of Japan. Aciphex has $1.3 billion in annual sales,

Teva says generic Aciphex gets FDA approval  -  Feb 22, 2007
ReutersO: Quote, Profile , Research) said the US Food and Drug Administration granted final approval for its 20 mg Rabeprazole Sodium delayed-release tablets.

Thursday's Health Winners & Losers  -  Feb 22, 2007
TheStreet.com...lower despite the final approval from the Food and Drug Administration for rabeprazole sodium delayed-release tablets, a generic form of Aciphex.

Teva gets final FDA OK for generic acid-pump inhibitor tablets  -  Feb 22, 2007
MarketWatchTeva, an Israeli drug company, said Thursday it received 180 days of market exclusivity because its application for Rabeprazole sodium delayed-release

Teva Giving Eisai Heartburn  -  Feb 23, 2007
Motley FoolTeva figures it can gain large percentage of that market by selling its generic version of the drug, rabeprazole sodium, in a controlled-release tablet.

Proton Pump Inhibitor Pariet Tablets 10mg Receives Approval in ...  -  Jan 30, 2007
PharmaLive.com (press release),Adult patients should take the following three-drug regime twice a day, for seven days: rabeprazole sodium (10mg per dose, titer), amoxicillin (750mg per

Proton Pump Inhibitor Pariet(R) Tablets 10mg Receives Approval in ...  -  Jan 31, 2007
PipelineReview.com (press release),Announced today that the company's proton pump inhibitor Pariet® Tablets 10mg (generic name: rabeprazole sodium), in combination with the antibiotics

Eisai Prevails: Motion For Summary Judgement  Oct 31, 2006
...announced that they received court decisions on ANDA-related summary judgement motions for Aciphex® (Active Ingredient Name: rabeprazole sodium, Product Name ... -Patent Baristas, Eisai Receives Summary Judgment Motion Decisions in US Legal ...  Oct 8, 2006
...announce that they received court decisions on ANDA-related summary judgment motions for Aciphex® (Active Ingredient Name: rabeprazole sodium, Product Name in ... -Yahoo! News (press release) Eisai Inc. Breaks Ground for New Oncology Facility in Research ...  -  Nov 24, 2006
Expansion Management,...which is devoted to manufacturing Aricept (donepezil hydrochloride tablets) and Aciphex (rabeprazole sodium) tablets as well as formulation research and

Eisai Inc. Breaks Ground for New Oncology Facility in Research ...  -  Nov 13, 2006
Drug Newswire (press release),...and Aciphex(R) (rabeprazole sodium) tablets as well as formulation research and development and manufacturing of compounds for use in clinical trials.

Eisai Inc. Breaks Ground for New Oncology Facility in Research ...  -  Nov 13, 2006
Pharmaceutical Processing,...which is devoted to manufacturing Aricept® (donepezil hydrochloride tablets) and Aciphex® (rabeprazole sodium) tablets as well as formulation research

Eisai Inc. Announces Appointment of Vice President of Business ...  Jul 6, 2006
...with, for example, Pfizer and Janssen for Aricept(R) (donepezil hydrochloride tablets) and Aciphex(R)/Pariet(R) (rabeprazole sodium) tablets, respectively. ... -PR Newswire

Eisai Inc. Announces Appointment of Vice President of Business ...  Jul 6, 2006
...with, for example, Pfizer and Janssen for Aricept® (donepezil hydrochloride tablets) and Aciphex®/Pariet® (rabeprazole sodium) tablets, respectively. ... -Yahoo! News



Eisai Applies for a New Indication of Non-Erosive Gastro ...  Mar 27, 2006
...company has filed an application for a new indication of non-erosive gastro-esophageal reflux disease for Pariet (generic name: rabeprazole sodium), a proton ... - PharmaLive.com



Teva gets tentative approval for generic AcipHex  Feb 16, 2006
...that the US Food and Drug Administration has granted tentative approval for its abbreviated new drug application (ANDA) for Rabeprazole Sodium Delayed-Release ... - Globes,

Piecing the perfect business model  Feb 23, 2006
...place. For instance GSK has in-licensed Paritec (rabeprazole sodium) from Eisai Pharmaceuticals India to co-promote it in India. ... - Express Pharma Pulse,

Japanese Stocks Fall, Property Stocks Decline, Sony Drops  Feb 16, 2006
Final permission to sell tablets containing the drug's active ingredient, rabeprazole sodium, is expected when a court order protecting Eisai's patent expires ... - Bloomberg

Thu: TASE takes a nap  Feb 16, 2006
...and US Food and Drug Administration (FDA) tentative marketing approval for its abbreviated new drug application (ANDA) for Rabeprazole sodium delayed-release ... - Globes,

Mylan Announces Tentative Approval for Rabeprazole Sodium Delayed ...  Jan 19, 2006
...and Drug Administration has granted tentative approval for Mylan Pharmaceuticals Inc.'s Abbreviated New Drug Application for Rabeprazole Sodium Delayed-release ... - Finanzen.net

Generics Give Originators Heartburn  Jan 20, 2006
Whether its Nexium's esomeprazole, Prilosec's omeprazole, Prevacid's lansoprazole, or Aciphex's rabeprazole sodium, all are included in a family known as ... - Motley Fool

Mylan tentatively OK'd for generic Aciphex  Jan 19, 2006
Mylan Laboratories said that the Food and Drug Administration has granted tentative approval to the company to market rabeprazole sodium delayed-release ... - United Press International

(PRN) - Regulating the Internet? 'Still a very bad idea,' Says ...  Jan 19, 2006
Republican Endorsement ... [+. PRN) - Mylan Announces Tentative Approval for Rabeprazole Sodium Delayed-Release Tablets ... [+. PRN ... - Bolsamania.com

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional